Search research articles
Contact Us
Filters
Showing results (81-90 of 165) with videos related to
Page
of 17
Sort By:
Plos One
|
October 16, 2020
A realist review of advance care planning for people with multiple sclerosis and their families
Laura Cottrell, Guillaume Economos, Catherine Evans, et al.
Plos One
|
May 26, 2022
"I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study
Jonathan Koffman, Clarissa Penfold, Laura Cottrell, et al.
Neurobiology of Disease
|
February 11, 2014
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study
Paolo Giannetti, Marios Politis, Paul Su, et al.
Immunology
|
August 3, 2017
Programmed death 1 is highly expressed on CD8<sup>+</sup> CD57<sup>+</sup> T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
Maria T Cencioni, Roberta Magliozzi, Richard Nicholas, et al.
Neurology
|
March 13, 2015
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis
Miriam Mattoscio, Richard Nicholas, Maria P Sormani, et al.
Applied Health Economics and Health Policy
|
May 18, 2022
ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients
Kristyna Lacinova, Praveen Thokala, Richard Nicholas, et al.
The Lancet. Neurology
|
June 11, 2017
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Dennis Chan, Sophie Binks, Jennifer M Nicholas, et al.
Nature Reviews. Neurology
|
November 27, 2025
Towards primary prevention of multiple sclerosis
Ruth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.
Journal of Neuroinflammation
|
December 8, 2019
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis
Roberta Magliozzi, Owain William Howell, Pascal Durrenberger, et al.
Multiple Sclerosis and Related Disorders
|
March 20, 2015
A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe
Gavin Giovannoni, Brigit de Jong, Tobias Derfuss, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 165) with videos related to
Sort By:
Page
of 17
Plos One
|
October 16, 2020
A realist review of advance care planning for people with multiple sclerosis and their families
Laura Cottrell, Guillaume Economos, Catherine Evans, et al.
Plos One
|
May 26, 2022
"I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study
Jonathan Koffman, Clarissa Penfold, Laura Cottrell, et al.
Neurobiology of Disease
|
February 11, 2014
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study
Paolo Giannetti, Marios Politis, Paul Su, et al.
Immunology
|
August 3, 2017
Programmed death 1 is highly expressed on CD8<sup>+</sup> CD57<sup>+</sup> T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
Maria T Cencioni, Roberta Magliozzi, Richard Nicholas, et al.
Neurology
|
March 13, 2015
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis
Miriam Mattoscio, Richard Nicholas, Maria P Sormani, et al.
Applied Health Economics and Health Policy
|
May 18, 2022
ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients
Kristyna Lacinova, Praveen Thokala, Richard Nicholas, et al.
The Lancet. Neurology
|
June 11, 2017
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Dennis Chan, Sophie Binks, Jennifer M Nicholas, et al.
Nature Reviews. Neurology
|
November 27, 2025
Towards primary prevention of multiple sclerosis
Ruth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.
Journal of Neuroinflammation
|
December 8, 2019
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis
Roberta Magliozzi, Owain William Howell, Pascal Durrenberger, et al.
Multiple Sclerosis and Related Disorders
|
March 20, 2015
A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe
Gavin Giovannoni, Brigit de Jong, Tobias Derfuss, et al.
Page
of 17